|
EXOC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.605600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.212800E-01 |
| Normal-vs-Stage2 |
2.540600E-01 |
| Normal-vs-Stage3 |
5.078800E-03 |
| Normal-vs-Stage4 |
2.364700E-03 |
| Stage1-vs-Stage2 |
4.698800E-01 |
| Stage1-vs-Stage3 |
1.371510E-02 |
| Stage1-vs-Stage4 |
9.740300E-03 |
| Stage2-vs-Stage3 |
4.043600E-01 |
| Stage2-vs-Stage4 |
3.131400E-01 |
| Stage3-vs-Stage4 |
7.496000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.698200E-02 |
| Normal-vs-AfricanAmerican |
5.860100E-03 |
| Normal-vs-Asian |
3.276200E-01 |
| Caucasian-vs-AfricanAmerican |
1.264590E-01 |
| Caucasian-vs-Asian |
8.645200E-01 |
| AfricanAmerican-vs-Asian |
6.905400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.063750E-02 |
| Normal-vs-Female |
2.487600E-01 |
| Male-vs-Female |
1.784770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.679400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.658000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.124130E-02 |
| Normal-vs-Age(81-100Yrs) |
1.961990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.603800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.614400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.038800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.501820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.208400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.458600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.746230E-01 |
| Normal-vs-Grade 2 |
5.995400E-01 |
| Normal-vs-Grade 3 |
6.320100E-03 |
| Normal-vs-Grade 4 |
3.95850000000086E-05 |
| Grade 1-vs-Grade 2 |
2.763000E-01 |
| Grade 1-vs-Grade 3 |
1.905950E-02 |
| Grade 1-vs-Grade 4 |
1.024450E-03 |
| Grade 2-vs-Grade 3 |
2.212200E-02 |
| Grade 2-vs-Grade 4 |
1.229830E-04 |
| Grade 3-vs-Grade 4 |
2.586100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.980000E-01 |
| Normal-vs-ccB subtype |
8.960300E-04 |
| ccA subtype-vs-ccB subtype |
1.62096999999362E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.393450E-01 |
| Normal-vs-N1 |
3.163500E-03 |
| N0-vs-N1 |
1.113560E-01 |
|
|
